SPRY vs. STZ

In the year-to-date period, SPRY achieves a 36.78% return, which is significantly higher than STZ's -18.40% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and Constellation Brands, Inc. (STZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SPRY Sharpe Ratio is 0.91, which is higher than the STZ Sharpe Ratio of -0.90. The chart below compares the historical Sharpe Ratios of SPRY and STZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

SPRY has not paid dividends to shareholders, while STZ's dividend yield for the trailing twelve months is around 2.27%.

The maximum SPRY drawdown since its inception was -95.20%, roughly equal to the maximum STZ drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for SPRY and STZ.

Silverback Therapeutics Inc (SPRY) has a higher volatility of 19.36% compared to Constellation Brands, Inc. (STZ) at 6.73%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than STZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Silverback Therapeutics Inc and Constellation Brands, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.